Thanks, Paul. Good morning everyone. Before I get into the results, I'd like to address the 8-K and subsequent restatements that we're filed today. This past November 2, the Audit Committee of the Board of Directors of Titan International concluded that the previously issued consolidated financial statements for the years ending December 31, 2013 and 2014 and quarters ending March 31, 2014 and 2015, June 30, 2014 and 2015 and September 30, 2014, should no longer be relied upon due to errors in the accounting for the shareholders' agreement and related redeemable non-controlling interest in the company's investment in Voltyre-Prom. Titan did not correctly classify the redeemable non-controlling interest on the balance sheet as mezzanine equity, which is presented below liabilities and above equity. The earnings per share calculation was also affected due to the redeemable non-controlling interest balance exceeding the carrying value of the investment. I want to make this point, the corrections to earnings per share are not operational as they do not effect revenue, operating expenses, net income or cash flows. So with that, let's turn our attention to the operations of the business. Q3 was a challenging quarter for Titan, as has been noted by both Morry and Paul. But despite the difficult quarter we've adapted well by continuing to reduce our headcounts commensurate with volume and as Paul indicated going well beyond headcount reduction in terms of improving profitability of the business. Our profit optimization efforts that materialized in the first half are still hard at work. While we were down significantly in sales to both prior year Q3 and year to date, our gross margin rate performance in Q3 eroded only 120 basis points and for year-to-date has actually improved 100 basis points. So, let's begin talking about revenue. Sales for the quarter were at $309 million. This was down $141 million or 31.3% from prior year. The quarter over quarter decrease was driven mostly by currency and reductions in our ag segment. So there's been lot of discussion around ag, comprising $101 million or 72% of the variance. More specifically, when you separate out currency, the entire ag variance was attributable to North America. I referenced currency. This drove a reduction in sales of $54 million on the quarter versus prior year. This impact was felt across all the international locations -- our undercarriage, Russia, Latin America, Europe and Australia businesses. The most significant movements were represented by the ruble and real. If you adjust for the currency impacts, sales declined 19.3% versus the reported 31.3%. So as we break down our segments, let's start with ag. There isn't anything to say here from a driver perspective that isn't already known or hasn't already been discussed. From our perspective, sales had deteriorated more than we projected. It was back in Q1 that many in our industry were projecting growth in 2016. It was just several months ago that one of our OE customers was saying with confidence that they believe 2016 would be flat. Now many in the industry pointing to another year of potentially lower sales in 2016. The OEM market continues to deteriorate as the two primary forces in lower farm income and high used inventory continue to plague the industry. Specific to Titan, ag in total was down $47 million or 21% when you exclude currency impact. North American ag was down $52 million or 33% -- $42 million or 82% of this erosion was driven by reductions associated with our OE customers and so that was referenced a little bit earlier by both Morry and Paul. From a product perspective, $41 million or 80% of the same North American ag reduction was a result of reduced demand for high-horsepower equipment. In Europe, continued decline in ag still has our large OE customers implementing line speed reductions and layoff days to reduce production volumes. In offset to that, we continue to win new business both in Europe and Turkey. Specifically, we won additional business with our largest Turkey customer, yielding 40,000 units this year. Additional wins in Titan Italy and France will drive 40,000 of additional units into next year. Latin America -- they continue to suffer from a number of negative forces, deep political crisis, weak GDP, increasing unemployment and high inflation. The credit rating of the country was downgraded by both S&P and Fitch. 2015 has been the worst year for OE, ag and construction in the past six years. So, as a consequence and I've said this on previous calls, this has really driven intense competitive pricing pressure, specifically in Brazil. Our Titan team in Brazil has been admirable in terms of their performance and perseverance to drive forward in the face of all these obstacles. They've been very diligent to reduce cost and ensure competitiveness in a very, very difficult market. A quick comment on our undercarriage Russia and Australia businesses -- when you exclude currency impact, each of them actually showed a small growth for both the quarter and year to-date. Let's turn our attention to earthmoving construction. Our sales for earthmoving construction were down $27 million or 17.5% from prior year when adjusting for currency. The currency impact of $15 million for the quarter was attributable to mostly the euro devaluation negatively impacting our undercarriage business. Our North American business experienced the largest volume decline at 29%. Even when adjusting for currency our rest of the world businesses all experienced negative growth, with the lone exception of our Europe Wheel business. The Europe's Wheel business just rolled out a new innovative single piece wheel. Ultimately we fully expect all clean manufactures to convert to this new technology. So, it's like a consumer because the results can be misleading. When adjusting for currency the sales were down $13 million or 19% from prior year. Another view, another way to look at the experience -- $21 million of the gross $28 million miss in consumer is driven by Latin America, where nearly the entire miss comprises either FX or supply agreements. And just to remind everybody we are no longer selling compound to Goodyear to produce treated fabric that we purchased back from them. We brought this activity in-house as a profit initiative. So again kind of building on Paul's comment going well beyond headcount reduction. We're turning over every rock in terms of how we can optimize profit, and this is yet another example of that. But it did eliminate $10 million of sales on the quarter, but improved profitability. When we adjust for FX and these Latin America supply agreement that I just referenced with Goodyear, sales declined only $5 million or 7.4% versus the reported 41%. So quite a contrast in terms of what was reported. So with the first three quarters completed that puts sales just under $1.1 billion year-to-date compared to $1.5 billion last year representing an erosion of 28.1%. As with Q3 the story is fairly consistent, ag currency comprises $359 million or 84% of the total net sales variance year-to-date. If you adjust for the $156 million currency impact, our sales erosion drops to 260 net -- $269 million or 17.8%. Let move on to gross margins where we've been diligent holding our own despite the significant sales decline. Our gross margin dollars were down $17.5 million. Our gross margin rate performance of 8.5% was down 120 basis points to prior year, on a $141 million or 31% plus sales. As I continue to state on these calls while we have battled to overcome the sales decline, we've also had to contend with the weaker mix as most of the ag erosion is related to high horsepower equipment, a higher-margin product category for us. During Q2 we reported an improvement of 200 basis points for Q2 year-to-date against the 27% sales decline and I believe Paul referenced this earlier -- we had very good performance in the first half. So, the logical question would be what happened in Q3, as the sales decline is consistent yet the gross margin rate is lower. I want to remind everybody Q3 and Q4 are historically our lowest sales quarters of the year, they can be as much as 25% less or more on -- against the first half. So while the sales decline Q3 over Q3 is consistent with year-to-date, second-half sales represent a significant decline from first half. To simplify my point and Paul mentioned it earlier we're cutting in the bone relative to fixed cost in our staffing structures at these low sales levels. And I'll talk a little bit more about this later. We've been talking for several quarters regarding our profit optimization framework. We continue to realize the benefits of our efforts. In fact we expect to show slightly improved gross margin rate performance for full-year despite the significant sales decline in this difficult back half. Net material cost reductions are across the board, natural rubbers, synthetic rubber, carbon black, fabric and chemicals. As we've continued to reference on these calls, we have significantly improved our procurement of raw materials through the centralization of purchasing into our new supply chain organization. We've been procuring better than our benchmarks where generally this is not the case historically. We are active in exploring additional initiatives on the steel side as well. So, we continue to demonstrate that we have been proactive in real-time in reducing headcount in our plans commensurate with anticipated lower production levels. Ideation and execution of profit optimization issues have been integral to driving improvement and productivity across all our businesses. But one exception to this is our North America tire business where the sales reductions translate nearly one-to-one in lower production levels in the plants as there's no effect of currency. While they've been equal to the task and attacking cost, this links back to the cutting into the bone comment that both Paul and I've made earlier. But with that being said they've generated at decremental margin of negative 2.2% year-to-date, which means they're actually generating positive margin on lower sales. Quick note on operating expenses -- SG&A, R&D and royalty are down $6 million to prior year and $22 million year-to-date. And while there are a series of puts and takes across these categories, this is primarily a decrease related to profit optimization and FX. And as I've stated in the past couple of quarters, our operating expense structure has historically been lean. It's obviously been climbing as a percent of sales as a function of math against the reduction sales. We continue to pursue investment or redeployment so to speak in areas of strategic nature. We have made and we will continue to make investments in technology and skilled resources. So moving down the P&L, let's talk about foreign exchange loss. We experienced a loss of $15.3 million for the quarter, primarily from our intercompany balances. This is not -- this does not represent a cash impact. This was $2 million unfavorable to prior year. As we have discussed over the past several quarters, we've taken a number of actions to mitigate risk in foreign exchange through balance reductions, reclassification and our new hedging practice. Year to date our hedge is in a positive $3.3 million positioning and $4.5 million inception to date. Unfortunately, Russia and Australia were driving the lion's share of the Q3 loss, are cost-prohibitive to hedge and are not a reclassification consideration at this time. So let's summarize and bring this to bottom line for profit. Our income from operations was a loss of $14.5 million. This is $12 million worse than prior year, resulting in a decrement margin of 8.5%. When you look at year-to-date income from operations, the decrement margin improves to 2.2%, representing only a $9 million flow through on $425 million lower sales. So, this is a testament to the unrelenting effort of our Titan team to reduce costs and optimize profit. Adjusted net income attributable to Titan is a $31.5 million loss or $0.59 per share adjusted loss and EBITDA at $2.7 million. This compares to prior year adjusted net income attributable to Titan at a $7.2 million loss or $0.13 per share adjusted loss and EBITDA at $22.9 million. For nine months ended this year adjusted net income attributable to Titan is $27 million or $0.50 per share adjusted loss and $50.8 million of EBITDA. This compares to adjusted net income attributable to Titan of $3.4 million or $0.06 per share adjusted loss and $80.2 million of EBITDA from prior year. Let's touch on a few balance sheet items real briefly, for the quarter AR is down $41 million from Q2, primarily a function of revenue as DSOs were flat. AR is down $65 million from Q3 of prior year, driven by lower revenue, DSOs have experienced a slight erosion. Inventory is slightly below Q2 levels, but DSIs have climbed slightly as we've been working with some consignment programs to battle for more share. AP is slightly down from Q2 and down $41 million from Q3 prior year due to revenue decline offset in part by a three day improvement DPM. And our EVA framework that Paul mentioned earlier, while the initial focus and emphasis has been on productivity and profitability growth that's seen though our strides with gross margin, working capital will also become an acute focus for value creation. And regards to PP&E, we continue to spend under our depreciation expense generating cash. As stated in previous quarters we have been carefully scrutinizing capital that ensures strategic alignment, positive EVA returns and cash generation. We expect to spend approximately $10 million in Q4, bringing our full year capital to spend to $45 million. This is below our internal plan and anticipated full year depreciation of $65 million, generating $20 million of cash for the year. So speaking of cash, cash ended the quarter up $6 million to Q2 at $194 million and this is down $8 million to 2014 year end. We are well aware that concerns persist over our liquidity and cash flow as we fight through these down markets. We continue to be mindful of our cash position and manage it diligently. I indicated on the last call that it was our goal to be cash neutral at year end. We're projecting this is -- this will not be likely, but expect to use only $9 million of cash in the Q4 and end the year at approximately $185 million. Let's turn our attention to debt. At 5.13 our net debt trailing adjusted EBITDA calculation has deteriorated one year ago from 3.19. Our actual debt level is slightly down from year ago. So this is just a function of math, as this downturn -- through this downturn we've dropped off higher earnings quarter and substitute with lower earning quarters. I want to make a comment, and make everybody aware that our convertible notes are due January 2017, so in in about 15 months. We are proactively managing this, exploring a number of alternatives to address this maturity. So wrapping up, I believe our year to date results are admirable in the face of some very difficult end markets accompanied by significant sales erosion. We've improved our gross margin rate performance by 100 basis points on 27% less sales. Our decremental margin at 2.2% is exceptional and while there has been a lot accomplished by our One Titan team, there's still lot of diligence ahead of us as we persevere through these challenging times. And I know I sound like a broken record when I say this, but I genuinely believe that we will be in a position to couple the ultimate market recovery with the significant improvements in our professional business practices that will result in a very lucrative outcome for our shareholders in the future. So with that, I'd like to turn the call back over to the operator for questions.